ConsumerDaily Briefs

Daily Brief Consumer: Sanei Architecture Planning, Amorepacific Group, Trent Ltd, China Resources Beer Holdings, JD Health International , Shakey’s Pizza, JD.com Inc (ADR), JD.com , Golf Digest Online and more

In today’s briefing:

  • Sanei Architecture Planning (3228) Finds Saviour from Mafia-Linked Former Boss and Majority Owner
  • Amorepacific Group: SoTP Valuation and Meaning of Min-Jung Suh Taking One Year Leave of Absence
  • NIFTY NEXT50 Index Rebalance: Five Changes; Big Impact; Cross Index Flow
  • Chongqing Brewery (600132 CH) Limit Up 10% Today After Results Beat; Buy China Resources Beer
  • JD Health 1H2023: Reports Operating Profits; Margin Upside Is Very Limited
  • Shakey’s Pizza: Q2 2023 Stellar, Increasing Guidance to 30% YoY Top/Bottomline Growth
  • Jindong (JD US): We Would Stay on the Sideline
  • JD (9618 HK): 2Q23, Main Business Began to Recover, Buy
  • [JD Health (6618 HK, BUY, TP HK$65) TP Change]: Benefit of Alternative Channel Starts to Show
  • 2Q Follow-Up – Golf Digest Online (3319 JP)


Sanei Architecture Planning (3228) Finds Saviour from Mafia-Linked Former Boss and Majority Owner

By Travis Lundy

  • [cue Tom Hardy gif saying “That’s Bait”]. But yes, this story has a backstory to the Japanese underworld, and while the original sin may have been minor, it’s everything.
  • The firm was raided, the CEO resigned, a govt authority “recommended” Sanei get rid of Mr Koike’s influence, banks got antsy, employee morale dropped. Sanei needed a saviour.
  • Koike-San asked Open House (3288 JP) to buy his shares. They agreed to take over the company. It’s basically a done deal with a possible twist.

Amorepacific Group: SoTP Valuation and Meaning of Min-Jung Suh Taking One Year Leave of Absence

By Douglas Kim

  • About a week ago, it was announced that Chairman’s elder daughter Min-Jung Suh will take a long one year leave of absence.
  • Chairman Suh is very dissatisfied with the company’s results in the past three years and wants to shake up the company to improve its operations, in our view. 
  • Our base case NAV valuation of Amorepacific Group (002790 KS) is 39,611 won, which is 29% higher than current price.

NIFTY NEXT50 Index Rebalance: Five Changes; Big Impact; Cross Index Flow

By Brian Freitas


Chongqing Brewery (600132 CH) Limit Up 10% Today After Results Beat; Buy China Resources Beer

By Steve Zhou, CFA

  • Chongqing Brewery Co A (600132 CH) announced a impressive earnings beat last night, with net profit up 24% yoy in 2Q23.  Stock is limit up (10%) today.
  • The results confirm the premiumization thesis of the China beer sector is in tact.
  • Buy China Resources Beer Holdings (291 HK); take advantage of the overall H-share market weakness and unfounded fear on deflation.   

JD Health 1H2023: Reports Operating Profits; Margin Upside Is Very Limited

By Shifara Samsudeen, ACMA, CGMA

  • JD Health reported 1H2023 results yesterday. 1H revenue increased 34.0% YoY to RMB27.1bn (vs consensus RMB27.5bn) and reported an OP of RMB943.9m (vs consensus RMB753.2m) vs RMB60.1m in 1H2022.
  • Though the company made OPM of 5.7% in 1Q2023, 1H2023 OPM was 3.5% in line with our analysis that OPM in excess of 2-3% may not be possible in LT.
  • There is very little upside for GPM to improve unless the company’s high-margin service business takes off at a higher rate which seems unrealistic to us.

Shakey’s Pizza: Q2 2023 Stellar, Increasing Guidance to 30% YoY Top/Bottomline Growth

By Sameer Taneja

  • We attended the Shakey’s Pizza (PIZZA PM) conference call for H1 FY23. Management was upbeat and guided 30% top/bottom line growth for FY23 ( up from 20% in Q1 FY23)
  • The company reported its highest-ever quarterly systemwide sales of 4.6 bn pesos ( up 29% YoY) due to network expansion, dine-in recovery, and, to a certain extent, price hikes.
  • Trading at a 12.9x/9.9x FY23e/24e PE, the stock is cheap, and growth of 20% CAGR over the next 3-4 years is not being factored in. 

Jindong (JD US): We Would Stay on the Sideline

By Eric Chen

  • JD reported 2Q results that were slightly better than the street expected.
  • But the set of results did little to alleviate our concerns about the structural challenges JD need to combat.
  • We still don’t think JD represents a viable investment case due to its lack of growth catalysts (vs. PDD) and attractive valuation (vs. Alibaba). We would stay on the sideline.

JD (9618 HK): 2Q23, Main Business Began to Recover, Buy

By Ming Lu

  • The main business line, home appliance began to grow by two digits.
  • Logistics revenue continued to grow strongly by 51% YoY and can still break even.
  • The operating profit rose to RMB7.3 bn in 2Q23 versus RMB3.8 bn in 2Q22.

[JD Health (6618 HK, BUY, TP HK$65) TP Change]: Benefit of Alternative Channel Starts to Show

By Shawn Yang

  • JDHealth (JDH) reported C1H23 top line, non-IFRS operating profit and IFRS net income 9.3%, 17% and 162% above our estimates. 
  • We believe that with years of tightening NDRL and the recent hardline anti-corruption campaign, 
  • More and more pharmaceuticals and patients are looking for alternative channels, which bodes well for JDH in the long run; We raise TP from HK$57 to HK$65 and reiterate BUY

2Q Follow-Up – Golf Digest Online (3319 JP)

By Sessa Investment Research

  • Post-merger integration (PMI) for SkyTrak business was largely completed during the 1H, and the GOLFTEC ANYWHERE initiative is now in full swing.
  • GOLFTEC continues to steadily open new corporate centers.
  • Following 1H unit sales of 5,000 units (new SkyTrak+ only launched at the end of May), the Company expects SkyTrak 2H unit sales of 10,000+ units. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars